oracle puts it out there....., page-70

Completely agree mate, although I think the company didn't have much choice but to announce something regarding GSK, because we had alot of information about it before and we knew it was regarding non-powered oral care with GSK etc etc,

I was more referring to all of these products with P&G that we have no idea about (i.e products 2 to 8), if we don't keep track of how much products are "under evaluation" vs "under development" vs "in clinical evaluations" then plenty of products that are "under evaluation" or "under development" can come and go from the list and we would be none the wiser... I *think* that is what may have caused some of the discrepancies between some of the announcements/broker blog posts etc (i.e 3, 4, 5 products under development)